NCT00612625View on ClinicalTrials.gov

Near Normalisation of BG Improves the Potentiating Effect of GLP-1

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

July 31, 2004

Study Completion Date

December 31, 2004

Conditions
Diabetes Mellitus Type 2
Interventions
DRUG

glucagon-like peptide-1

continuous infusion of GLP-1 (1½ pmol/kg/min)

DRUG

Saline

continuous infusion of saline

Trial Locations (1)

Unknown

Dept. of Endocrinology, Hvidovre Hospital, Copenhagen

All Listed Sponsors
lead

Hvidovre University Hospital

OTHER

NCT00612625 - Near Normalisation of BG Improves the Potentiating Effect of GLP-1 | Biotech Hunter | Biotech Hunter